Eevia Health Plc receives a 130 KSEK / 11 KEUR sales order for a Chaga extract
Eevia Health Plc (”Eevia” or ”The Company”) has received an 11 KEUR sales order for Feno-Chaga® Organic from a health-food customer in Finland.
The direct customer is one of the largest well-being brand owners in Finland. It is one of the fastest-growing brand owners in the Superfood segment, with operations in several Nordic countries. Their selection has been supplemented with products that support comprehensive well-being, such as dietary supplements, drinks, and bars.
The sales value to Eevia of this new order is c. KEUR 11 EUR. The product is a chaga extract standardized on beta-glucans and polyphenols with immunomodulating effects. Eevia Health is the only company in the world with a clinical study on Chaga extract, with positive results, for which the company is preparing a scientific manuscript for a peer-reviewed journal.
The FENO-CHAGA™ ORGANIC is a standardized extract in powder form made from wild-harvested chaga from Finland, a mushroom (strictly speaking a fungi), growing naturally on birch trees.
The order is expected to be followed by further repeat orders in the future.
For further information, please contact:
Stein Ulve, CEO, Eevia Health Plc
Email: [email protected]
Telephone: +358 400 22 5967
INFORMATION ABOUT EEVIA HEALTH PLC
Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients in dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.
Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia’s other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.
Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.
To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn@EeviaHealth.
